Under certain circumstances, clinicians treating patients with isavuconazole for invasive aspergillosis or mucormycosis may use therapeutic drug monitoring. However, the accuracy and reproducibility of the various assays used by different laboratories for the quantification of isavuconazole plasma concentrations have yet to be determined
Contains fulltext : 80118.pdf (publisher's version ) (Open Access)An international...
OBJECTIVES: Since 2007 the Dutch Association for Quality Assessment in Therapeutic Drug Monitoring (...
ABSTRACT Isavuconazole (ISZ) is a newly available broad-spectrum triazole agent recently approved fo...
Background: Under certain circumstances, clinicians treating patients with isavuconazole for invasiv...
Isavuconazole (ISA) is a triazole antifungal agent recommended for treatment of invasive aspergillos...
Isavuconazole is a broad‐spectrum triazole antifungal drug recently approved for the therapy of both...
Item does not contain fulltextAlthough mucormycoses (formerly zygomycoses) are relatively uncommon, ...
Invasive fungal infections (IFIs) are occurring with increasing incidence and are associated with si...
International audienceA new analytical method was developed for the routine Therapeutic Drug Monitor...
Isavuconazole is a newer broad-spectrum triazole approved for the treatment of invasive fungal disea...
Isavuconazole, the active moiety of the water-soluble prodrug isavuconazonium sulfate, is a triazole...
Isavuconazole, the active moiety of the water-soluble prodrug isavuconazonium sulfate, is a triazole...
BackgroundIsavuconazole is an antifungal drug used for treatment of invasive fungal infections. Crit...
Isavuconazole is a newer broad-spectrum triazole approved for the treatment of invasive fungal disea...
Purpose. Invasive aspergillosis is a prevalent fungal disease, especially in Asian countries with a ...
Contains fulltext : 80118.pdf (publisher's version ) (Open Access)An international...
OBJECTIVES: Since 2007 the Dutch Association for Quality Assessment in Therapeutic Drug Monitoring (...
ABSTRACT Isavuconazole (ISZ) is a newly available broad-spectrum triazole agent recently approved fo...
Background: Under certain circumstances, clinicians treating patients with isavuconazole for invasiv...
Isavuconazole (ISA) is a triazole antifungal agent recommended for treatment of invasive aspergillos...
Isavuconazole is a broad‐spectrum triazole antifungal drug recently approved for the therapy of both...
Item does not contain fulltextAlthough mucormycoses (formerly zygomycoses) are relatively uncommon, ...
Invasive fungal infections (IFIs) are occurring with increasing incidence and are associated with si...
International audienceA new analytical method was developed for the routine Therapeutic Drug Monitor...
Isavuconazole is a newer broad-spectrum triazole approved for the treatment of invasive fungal disea...
Isavuconazole, the active moiety of the water-soluble prodrug isavuconazonium sulfate, is a triazole...
Isavuconazole, the active moiety of the water-soluble prodrug isavuconazonium sulfate, is a triazole...
BackgroundIsavuconazole is an antifungal drug used for treatment of invasive fungal infections. Crit...
Isavuconazole is a newer broad-spectrum triazole approved for the treatment of invasive fungal disea...
Purpose. Invasive aspergillosis is a prevalent fungal disease, especially in Asian countries with a ...
Contains fulltext : 80118.pdf (publisher's version ) (Open Access)An international...
OBJECTIVES: Since 2007 the Dutch Association for Quality Assessment in Therapeutic Drug Monitoring (...
ABSTRACT Isavuconazole (ISZ) is a newly available broad-spectrum triazole agent recently approved fo...